Dr. Reddys Labs (RDY) Posts Improved Q2 EPS of 50c/Share

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.50, versus $0.30 reported last year. Revenue for the quarter came in at $544 million, versus $429 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals